Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2005
05/03/2005US6887996 Compounds and their use
05/03/2005US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia
05/03/2005CA2201477C New pyrimidone derivatives with antifungal activity
04/2005
04/28/2005WO2005037843A1 Compositions useful as inhibitors of protein kinases
04/28/2005WO2005037825A2 Protein kinase inhibitors
04/28/2005WO2005037271A2 Large conductance calcium-activated k channel opener
04/28/2005WO2005037210A2 Photocleavable isotope-coded affinity tags
04/28/2005WO2005016931A3 Crystallisation of solid forms of clopidogrel addition salts
04/28/2005US20050090640 Mono-, oligo-and polythieno[2,3-b]thiophenes
04/28/2005US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide
04/28/2005US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent
04/28/2005US20050090509 Treating hyperproliferative disorders; N-(4,6-Dimethyl-pyridin-2-yl)-2-{3-fluoro-4-[2-(1-methyl- 1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-phenyl}-acetamide for example; receptor kinase inhibitors
04/28/2005US20050090400 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
04/28/2005CA2542113A1 Compositions useful as inhibitors of protein kinases
04/28/2005CA2542076A1 Substituted tricyclic compounds as protein kinase inhibitors
04/27/2005EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors
04/27/2005EP1525481A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
04/27/2005EP1525268A1 Functional fluorescent dyes
04/27/2005EP1525266A1 Site-specific labelling of proteins using cyanine dye reporters
04/27/2005EP1261327B1 Adenosine receptor modulators
04/27/2005EP1144411B1 Antihistaminic spiro compounds
04/27/2005EP1040098B1 Integrin receptor antagonists
04/27/2005EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/27/2005CN1609109A Prepn process of thione
04/26/2005US6884886 Process for preparing 6-aryl-4H-S-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines
04/26/2005US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases
04/21/2005WO2005035537A2 Substituted tricyclic heterocycles and their uses
04/21/2005WO2005007083A3 Chemical compounds
04/21/2005US20050085630 Photocleavable isotope-coded affinity tags
04/21/2005US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
04/21/2005US20050082525 polythiophenes such as poly-(4,8-dihexylbenzo[1,2-b;4,5-b']dithiophene), used as semiconductors or charge transport materials in optical, electro-optical or electronic devices, liquid crystal displays, optical films, transistors, integrated circuits, electroluminescent devices and detectors
04/21/2005CA2542008A1 Substituted tricyclic heterocycles and their uses
04/20/2005EP1524286A1 Poly(benzodithiophenes)
04/20/2005CN1608069A Selective androgen receptor modulators and methods for their identification, design and use
04/20/2005CN1197860C FAB I inhibitors
04/19/2005US6881850 Heterocyclically annellated indenochromene derivatives
04/19/2005US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis
04/14/2005WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
04/14/2005WO2005032527A2 Benzo (4, 5) thieno (2, 3-d) pyrimidin-4-ones and their use in therapy
04/14/2005WO2005007099A3 Pkb inhibitors as anti-tumor agents
04/14/2005WO2004113391A3 Improved pharmaceutical drug candidates and methods for preparation thereof
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080096 Condensed heterocyclic compounds
04/14/2005US20050080085 Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
04/14/2005CA2527617A1 Benzo-(4,5)-thieno-(2,3d)-pyrimidin-4-ones and their use in the treatment or prevention of a steroid hormone dependent disease or disorder
04/13/2005EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors
04/13/2005EP1246827B1 New polymorphic forms of olanzapine
04/13/2005CN1606553A Oxytocin agonistenoxytocin agonisten
04/12/2005US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine
04/07/2005WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
04/07/2005WO2004112714A3 Chemical compounds
04/07/2005WO2004098283A3 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
04/07/2005US20050075385 Substituted thienoimidazoles useful for disease treatment and prevention
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage
04/07/2005US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one
04/07/2005US20050075328 Such as (2'-methoxy-[1,1'-biphenyl]-4-yl)-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
04/07/2005US20050074748 Bioreactive agents
04/07/2005US20050074457 Simplified, high throughput screening for identification of heat shock protein 90 ligands selective for high affinity form
04/07/2005DE10341240A1 Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted Thienoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
04/06/2005EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone
04/06/2005EP1519735A2 Assays and implements for determining and modulating hsp90 binding activity
04/06/2005EP1519728A1 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder
04/06/2005EP1414817B1 substituted isoindoles and the use thereof
04/06/2005EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity
04/06/2005CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives
04/06/2005CN1195737C HIV proteinase inhibitor
04/05/2005US6875761 Certain 1,3-disubstituted isoquinoline derivatives
04/05/2005CA2270086C New benzothiophene, benzofuranic and indolic derivatives, their preparation process and pharmaceutical compositions containing them
04/05/2005CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
03/2005
03/31/2005US20050070589 Pyrazolyl inhibitors of 15- lipoxygenase
03/31/2005US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
03/31/2005US20050070508 Modulators of receptor kinases such as VEGFR; treating cancer, benign hyperplasia; 6-[2-(1-Methyl-1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-naphthalene-1-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for example
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518859A1 Process for the purification of thiophenes
03/30/2005EP1517689A2 Selective analgesic agents
03/30/2005EP1248780B1 Di(het)arylaminothiophene derivatives
03/30/2005EP1194429B1 Potassium channel openers
03/30/2005CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872727 Polycyclic pyrimidine -2,4(1H,3H)-diones with functionalized alkyl residues at the 1- and/or 3-position(s); methods for their synthesis and pharmaceutical preparation
03/29/2005US6872574 Proteomic analysis
03/24/2005WO2005026177A1 Substituted piperazines of azepines, oxazepines, and thiazepines
03/24/2005WO2005026175A1 Thienopyrazoles
03/24/2005WO2005026174A1 Novel crystalline polymorphs of clopidogrel
03/24/2005WO2005026173A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
03/24/2005WO2005003138A3 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
03/24/2005WO2004108665A3 A process for preparation of clopidogrel
03/24/2005WO2004106344A3 Salts of clopidogrel and process for preparation
03/24/2005WO2004100947A3 Novel chemical compounds
03/24/2005US20050065352 Process for the purification of thiophenes
03/24/2005US20050065305 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices
03/24/2005US20050065170 Compounds
03/24/2005US20050065169 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
03/24/2005DE10337773A1 Kristallisation von festen Formen von Clopidogrel-Additionssalzen Crystallisation of solid forms of clopidogrel addition salts
03/24/2005CA2810312A1 Novel crystalline polymorphs of clopidogrel
03/24/2005CA2809750A1 Novel crystalline polymorphs of clopidogrel
03/24/2005CA2537695A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same